NeuroSense Therapeutics (NRSNW) Q3 2024 Earnings

30SepConfirmed
Mar 21
Jun 21
Q2 2024
Q3 2024
-0.35
-0.23
-0.12
0

Details

Expected EPS
-0.185
Actual EPS
-0.05
Surprise EPS
0.14
Surprise Percent
+72.97%

Description

NeuroSense Therapeutics (NRSNW) has reported earnings of -0.05 per share for Q3 2024.

0 Comments

Share your thoughts